Contraceptive progestins and gonadotropin secretion in vitro

Area of Science:

• Endocrinology
• Molecular Pharmacology

Background:

• Contraceptive progestins are widely used for hormonal birth control.
• Their mechanism of action on the hypothalamic-pituitary-gonadal axis requires further elucidation.
• Gonadotropin-releasing hormone (GnRH) regulates the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Purpose of the Study:

• To investigate the in vitro effects of contraceptive progestins on basal and GnRH-stimulated LH and FSH secretion.
• To explore the potential intracellular mechanisms, specifically inositol phosphate metabolism, involved in progestin action.
• To validate an in vitro bioassay for assessing the potency of progestational compounds.

Main Methods:

• Utilized rat pituitary cell cultures for in vitro bioassays.
• Administered various contraceptive progestins and progesterone at different concentrations and pre-incubation times.
• Measured LH and FSH secretion in response to GnRH stimulation.
• Investigated the impact of progestins on inositol phosphate metabolism following GnRH stimulation.

Main Results:

• Progestins significantly inhibited GnRH-induced LH and FSH secretion in a dose-dependent manner.
• Most progestins were more potent inhibitors than progesterone.
• Progestin pre-incubation altered cellular sensitivity to GnRH and, with prolonged exposure, suppressed gonadotropin release.
• Progestins, such as gestoden, inhibited GnRH-induced inositol phosphate production, indicating interference with this signaling pathway.

Conclusions:

• The in vitro bioassay with rat pituitary cells is effective for evaluating the potency of progestins on gonadotropin release.
• Contraceptive progestins interfere with GnRH-induced gonadotropin secretion, potentially by inhibiting polyphosphoinositide breakdown.
• This interference with intracellular signaling pathways represents a key mechanism of action for contraceptive progestins.